skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Dosimetry of D- and L-enantiomers of /sup 11/C-labeled tryptophan and valine

Conference ·
OSTI ID:5149565

We have previously reported the radiation dosimetry of /sup 11/C-labeled DL-tryptophan and DL-valine, as well as clinical pancreatic imaging studies with these agents. Because of significant uptake in both normal pancreas and in pancreatic tumors (thought to be due to the presence of the D-enantiomer), differential diagnosis of pancreatic carcinoma was not feasible. High-performance liquid chromatographic (HPLC) methods were developed for rapid resolution of /sup 11/C-labeled DL-tryptophan and DL-valine. Radiation dose estimates to the various organs in man were calculated for the D- and L-enantiomers of /sup 11/C-labeled tryptophan and valine, based on tissue distribution data in rats. The dose estimates were sufficiently low that 20-mCi doses of each of the enantiomeric amino acids were approved by the FDA for intravenous administration to humans. 21 refs., 3 tabs.

Research Organization:
Oak Ridge Associated Universities, Inc., TN (USA)
DOE Contract Number:
AC05-76OR00033
OSTI ID:
5149565
Report Number(s):
CONF-851113-8; ON: DE87000311
Resource Relation:
Conference: Radiopharmaceutical dosimetry symposium, Oak Ridge, TN, USA, 5 Nov 1985
Country of Publication:
United States
Language:
English

Similar Records

Metabolic fate of the carboxyl-carbon of valine
Conference · Sun Jan 01 00:00:00 EST 1984 · J. Nucl. Med.; (United States) · OSTI ID:5149565

DL-(carboxyl-/sup 11/C)tryptophan, a potential agent for pancreatic imaging; production and preclinical investigations
Journal Article · Wed Aug 01 00:00:00 EDT 1979 · J. Nucl. Med.; (United States) · OSTI ID:5149565

(1-/sup 11/C) DL-valine, a potential pancreas-imaging agent. [Rats, hamsters, rabbits, dogs]
Journal Article · Sun Jan 01 00:00:00 EST 1978 · J. Nucl. Med.; (United States) · OSTI ID:5149565